February 5, 2021

February 5, 2021

Alcohol related liver disease accounts for 50% of all liver disease, but the biology of why some individuals develop severe liver disease (cirrhosis) and other do not, remains uncertain, and management options remain exceedingly limited and centered around abstinence. In this series, we seek to address these knowledge and care gaps by highlighting state of the art knowledge and bringing together clinicians and investigators in a virtual forum. This will be a once monthly virtual seminar, featuring global experts in hepatology, addiction medicine and the basic science of liver disease to highlight state-of-the-art knowledge and an evidenced-based approach to the diagnosis and management of alcohol-related liver disease.

Target Audience

This activity is intended for Clinicians and Investigators with an interest in the biology and management of alcohol use disorder and alcohol-related liver diseases.

Learning Objectives

Upon completing this activity, participants will be able to:

  1. Assess the patient with alcoholicliver disease.
  2. Understand the fundamental driving forces behind liver injury from alcohol use.
  3. Provide multidisciplinary care addressing both alcohol use disorder and hepaticdysfunction.

Additional Information

Provided by: 

Massachusetts General Hospital & Mass General Brigham

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
02/05/2021
Course expires: 
04/01/2021
Event starts: 
02/05/2021 - 12:00pm
Event ends: 
02/05/2021 - 1:00pm
Cost:
$0.00

Jay Luther, MD
Director, MGH Alcohol Liver Center
Gastroenterology, Division of Medicine
Massachusetts General Hospital
Harvard Medical School

Russell Goodman, MD, PhD, DPhil
Gastroenterology, Division of Medicine
Massachusetts General Hospital
Harvard Medical School

Esperance Schaefer, MD, MPH
Gastroenterology, Division of Medicine
Massachusetts General Hospital
Harvard Medical School

Mark Thursz, MD
Chair, Department of Metabolism, Digestion & Reproduction
Professor, Hepatology
Imperial College London – London, United Kingdom

Mass General Brigham is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Mass General Brigham designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Price

Cost:
$0.00
Please login or register to take this course.